BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Tesla
TSLA
|
+$488M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$271M |
| 5 |
Abbott
ABT
|
+$253M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$642M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Visa
V
|
+$487M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$441M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$252M |
Sector Composition
| 1 | Technology | 18.06% |
| 2 | Financials | 12.01% |
| 3 | Consumer Discretionary | 9.98% |
| 4 | Healthcare | 8.94% |
| 5 | Communication Services | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XXII
2751
22nd Century Group
XXII
$6.39M
| – | – |
0
| – | – |
|
2752
Kopin
KOPN
$357M
| $24.5K | ﹤0.01% |
+2,989
| New | +$24.5K |
|
2753
Citizens
CIA
$271M
| $24.4K | ﹤0.01% |
4,610
-19,264
| -81% | -$102K |
|
2754
Alaunos Therapeutics
TCRT
$5.05M
| $24.2K | ﹤0.01% |
61
-385
| -86% | -$153K |
|
2755
HF Foods Group
HFFG
$174M
| $24K | ﹤0.01% |
4,544
-12,061
| -73% | -$63.8K |
|
2756
Stoke Therapeutics
STOK
$1.27B
| $23.9K | ﹤0.01% |
710
-3,477
| -83% | -$117K |
|
2757
Solid Biosciences
SLDB
$419M
| $23.8K | ﹤0.01% |
433
-290
| -40% | -$15.9K |
|
2758
Siebert Financial
SIEB
$110M
| $23.6K | ﹤0.01% |
4,909
+3,669
| +296% | +$17.6K |
|
|
CTT
2759
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $23.6K | ﹤0.01% |
2,016
-18,796
| -90% | -$220K |
|
2760
Hurco Companies Inc
HURC
$112M
| $23.5K | ﹤0.01% |
671
-2,598
| -79% | -$90.9K |
|
|
SPNE
2761
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $23.4K | ﹤0.01% |
1,143
-9,739
| -89% | -$200K |
|
2762
Mayville Engineering Co
MEC
$299M
| $23.4K | ﹤0.01% |
1,165
-2,965
| -72% | -$59.6K |
|
2763
Ardelyx
ARDX
$1.61B
| $23.4K | ﹤0.01% |
3,085
-15,334
| -83% | -$116K |
|
|
PAMT
2764
PAMT CORP Common Stock
PAMT
$246M
| $23.4K | ﹤0.01% |
1,772
-1,096
| -38% | -$14.5K |
|
2765
Akero Therapeutics
AKRO
$3.55B
| $23.3K | ﹤0.01% |
941
-781
| -45% | -$19.4K |
|
2766
VistaGen Therapeutics
VTGN
$108M
| $23.2K | ﹤0.01% |
+246
| New | +$23.2K |
|
2767
Funko
FNKO
$186M
| $23.2K | ﹤0.01% |
1,089
-11,133
| -91% | -$237K |
|
2768
KVH Industries
KVHI
$117M
| $23.2K | ﹤0.01% |
1,883
-5,761
| -75% | -$70.9K |
|
2769
Turning Point Brands
TPB
$1.81B
| $23.1K | ﹤0.01% |
505
-1,009
| -67% | -$46.2K |
|
|
LAND
2770
Gladstone Land Corp
LAND
$318M
| $22.6K | ﹤0.01% |
941
-5,353
| -85% | -$129K |
|
2771
CorMedix
CRMD
$985M
| $22.5K | ﹤0.01% |
3,281
-642
| -16% | -$4.4K |
|
2772
National Research Corp
NRC
$374M
| $22.5K | ﹤0.01% |
490
-1,262
| -72% | -$57.9K |
|
|
JNCE
2773
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $22.5K | ﹤0.01% |
3,303
-4,524
| -58% | -$30.8K |
|
2774
Alpha and Omega Semiconductor
AOSL
$873M
| $22.5K | ﹤0.01% |
739
-9,326
| -93% | -$283K |
|
2775
ACM Research
ACMR
$1.88B
| $22.4K | ﹤0.01% |
657
+375
| +133% | +$12.8K |
|